Table 1. Incremental cost-effectiveness ratios (ICER) from Medicare perspective.

	Expected 56-month discounted Medicare costs, 1996 U.S. dollars (95% CI)	Discounted Survival (Years)	Discounted Disease-free Survival (Years)	Survival ICER	DFS ICER
SFX, N = 43	$47,719 (29,672; 69,015)	3.0	2.1
HFX, N = 47	$58,124 (34,777; 74,729)	3.9	2.9	$11,728	$11,832
AHFX-S, N = 46	$52,488 (35,017; 72,988)	3.7	2.8	$7,042	$6,384
AFX-C, N = 51	$37,946 (23,635; 55,507)	3.2	2.3	-$80,272	-$44,605

SFX-Standard fraction radiotherapy; HFX-Hyperfractionated radiotherapy; AHFX-Accelerated Hyperfractionated radiotherapy with split; AFX-C-Accelerated Fractionated radiotherapy with concomitant boost